Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Delivery
Pharma
J&J puts ImmunityBio on defense mode in bladder cancer
J&J’s ambition in non-muscle invasive bladder cancer will likely tee off a showdown between its TAR-200 and ImmunityBio’s immunotherapy Anktiva.
Angus Liu
Apr 27, 2025 12:35pm
Halozyme sues Merck over subcutaneous Keytruda
Apr 24, 2025 2:41pm
Merck lays out subcutaneous Keytruda data amid patent brawl
Mar 27, 2025 11:00am
AstraZeneca inks $1.35B deal for subcutaneous cancer drugs
Mar 17, 2025 10:55am
Gilead's PrEP shows early promise in once-yearly dosing
Mar 11, 2025 2:30pm
Merck, Halozyme dig in for patent fight over injectable Keytruda
Mar 6, 2025 11:18am
